Category

Clinical Trials

Martin Olin

BerGenBio initiates Phase 1b/2a trial

October 14, 2022

BerGenBio has announced the initiation …

Nykode announces positive Phase 1/2 results

October 14, 2022

Nykode Therapeutics has announced clinical …

First US patient dosed in TILT’s Phase I study

October 11, 2022

TILT Biotherapeutics has announced that …

Orexo announces positive Phase I data

October 11, 2022

Orexo has announced positive results …

Ultimovacs announces positive three-year results

October 10, 2022

Ultimovacs has announced continuing positive …

Søren Bregenholt

Alligator announces positive safety data

October 5, 2022

Alligator Bioscience has reported positive …

Positive results from BioArctic’s Alzheimer’s study

September 29, 2022

BioArctic’s partner Eisai has announced …

Empros Pharma results published in scientific journal

September 27, 2022

The company’s study is published …

Carl-Magnus Högerkorp

Cyxone receives green light to start Phase 2b study

September 20, 2022

Cyxone has received approvals from …

AlzeCure reports new data from Phase I study

September 16, 2022

AlzeCure Pharma has received new …

Søren Bregenholt

Alligator Bioscience presents Phase 1b/2 data

September 14, 2022

Alligator Bioscience has announced a …

parkinsons

Dizlin Pharmaceuticals publishes data from pharmacokinetic study

September 8, 2022

The Gothenburg based company has …

Richard Godfrey

IRLAB’s partner initiates clinical studies

September 7, 2022

IRLAB Therapeutics have announced that …

BioInvent completes dose-escalation in Phase 1/2a trial

September 6, 2022

BioInvent International has announced the …

nerve cells istock

Peer-reviewed research supports TikoMed’s ILB’s mode of action

September 5, 2022

New research shows that ILB …

EpiEndo starts clinical trial with its lead molecule

September 2, 2022

EpiEndo Pharmaceuticals has received regulatory …

1
2
3
4
5
···
46